Enimmune Corporation (TPEX:6564)
18.15
-0.45 (-2.42%)
Apr 20, 2026, 12:55 PM CST
Enimmune Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 202.39 | 484.91 | 359.89 | 394.17 | 118.39 |
Short-Term Investments | 44.41 | 4.9 | 4.9 | 92.9 | 231.4 |
Cash & Short-Term Investments | 246.79 | 489.81 | 364.79 | 487.07 | 349.79 |
Cash Growth | -49.61% | 34.27% | -25.11% | 39.25% | -17.46% |
Accounts Receivable | 14.52 | 12.5 | 11.92 | 5.22 | 21.99 |
Other Receivables | 0.24 | 29.73 | 28.38 | 28.55 | 25.54 |
Receivables | 14.76 | 42.23 | 40.3 | 33.77 | 47.53 |
Inventory | 21.23 | 35.64 | 37.64 | 88.12 | 82.82 |
Prepaid Expenses | 33.84 | 2.58 | 4.9 | 2.37 | 2.05 |
Other Current Assets | 1.56 | 17.79 | 17.59 | 16.54 | 1.37 |
Total Current Assets | 318.18 | 588.04 | 465.21 | 627.87 | 483.55 |
Property, Plant & Equipment | 14.14 | 3.86 | 5.88 | 8.52 | 5.92 |
Other Intangible Assets | 99.08 | 104.17 | 109.27 | 114.38 | 119.48 |
Other Long-Term Assets | 24.71 | 27.63 | 24.47 | 24.33 | 1.12 |
Total Assets | 456.1 | 723.7 | 604.83 | 775.09 | 610.07 |
Accounts Payable | 2.85 | 2.95 | 18.06 | 4 | 10.36 |
Accrued Expenses | - | 19.4 | 32.39 | - | - |
Short-Term Debt | 125 | 100 | 40 | 20 | - |
Current Portion of Long-Term Debt | 10 | 2.24 | 2.13 | 2.11 | 2.09 |
Current Portion of Leases | 3.48 | 0.78 | 1.84 | 1.82 | 0.78 |
Current Unearned Revenue | - | - | - | - | 1.72 |
Other Current Liabilities | 132.37 | 114.35 | 77.28 | 76.02 | 19.88 |
Total Current Liabilities | 273.7 | 239.71 | 171.7 | 103.95 | 34.82 |
Long-Term Debt | 28.22 | 4.78 | 0.98 | 3.11 | 5.22 |
Long-Term Leases | 4.49 | - | 0.78 | 2.62 | - |
Total Liabilities | 306.41 | 244.49 | 173.46 | 109.68 | 40.04 |
Common Stock | 721.34 | 721.34 | 658 | 658 | 600 |
Additional Paid-In Capital | 25.67 | 160.64 | 11.56 | 168.02 | 17.27 |
Retained Earnings | -588.81 | -509.82 | -344.93 | -281.33 | -47.25 |
Comprehensive Income & Other | -8.51 | 1.91 | -2.68 | -0.15 | - |
Total Common Equity | 149.69 | 374.06 | 321.95 | 544.54 | 570.03 |
Minority Interest | - | 105.14 | 109.41 | 120.87 | - |
Shareholders' Equity | 149.69 | 479.2 | 431.36 | 665.41 | 570.03 |
Total Liabilities & Equity | 456.1 | 723.7 | 604.83 | 775.09 | 610.07 |
Total Debt | 171.19 | 107.8 | 45.73 | 29.66 | 8.08 |
Net Cash (Debt) | 75.6 | 382 | 319.06 | 457.41 | 341.7 |
Net Cash Growth | -80.21% | 19.73% | -30.25% | 33.86% | -17.02% |
Net Cash Per Share | 1.05 | 5.34 | 4.85 | 7.16 | 5.70 |
Filing Date Shares Outstanding | 72.03 | 72.13 | 65.8 | 65.8 | 60 |
Total Common Shares Outstanding | 72.03 | 72.13 | 65.8 | 65.8 | 60 |
Working Capital | 44.47 | 348.33 | 293.51 | 523.92 | 448.73 |
Book Value Per Share | 2.08 | 5.19 | 4.89 | 8.28 | 9.50 |
Tangible Book Value | 50.61 | 269.9 | 212.68 | 430.16 | 450.55 |
Tangible Book Value Per Share | 0.70 | 3.74 | 3.23 | 6.54 | 7.51 |
Machinery | - | 5.39 | 4.92 | 4.92 | 4.65 |
Leasehold Improvements | - | 2.6 | 2.6 | 2.6 | 2.52 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.